John David Finley, CEO, CFO, Director at PALISADE BIO, INC. (PALI), bought 15,000 shares at $0.54 ($8K) on 2023-09-27, disclosed to the SEC on 2023-09-29.
Open-market purchase of $8k PALI by CEO, CFO, Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| PALI | BUY | 2024-05-28 | $5K | — | Filing → |
| PALI | BUY | 2024-02-07 | $5K | — | Filing → |
| PALI | BUY | 2024-02-01 | $6K | — | Filing → |